Endovascular Recanalization Methods in Treatment of Chronic Lower Limb Ischemia: Modern State of Problem

Abstract

INTRODUCTION: The problem of treatment of patients with chronic lower limb ischemia (CLLI) remains extremely important to date. This is first of all due to increase in the number of patients with chronic obliterating diseases of peripheral arteries, which hold one of the leading positions in the structure of morbidity and disability of the population over 60 years. The progression of the disease with development of critical CLLI leads to amputation of the limb within five years in a third of patients. The first line therapy for CLLI is endovascular interventions both stand-alone and with use of hybrid approach, especially in patients with critical CLLI. In many cases of multi-level, especially multifocal lesions of arterial vessels, the choice of revascularization tactics is not yet completely defined.

CONCLUSION: In recent years, there has been a trend of using endovascular revascularization technologies in continued stenosis and occlusions of the lower limb arteries. However, there is an essential need to study their long-term results, as well as to clarify the indications for stenting in critical CLLI.

Keywords

atherosclerosis / chronic lower limb ischemia / angioplasty / stenting / amputation

References

[1] Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016

[2] Conte M.S., Bradbury A.W., Kolh P., et al. Global vascular guidelines on the management of chronic limb-threatening ischemia // Journal of Vascular Surgery. 2019. Vol. 69, No. 6S. P. 3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016

[3] Natsional’nyye rekomendatsii po diagnostike i lecheniyu zabolevaniy arteriy nizhnikh konechnostey. Moscow; 2019. (In Russ).

[4] Национальные рекомендации по диагностике и лечению заболеваний артерий нижних конечностей. М.; 2019.

[5] Pokrovskiy AV, Golovyuk AL. Sostoyaniye sosudistoy khirurgii v Rossiyskoy Federatsii v 2018 godu. Angiology and Vascular Surgery. 2019;25(2S):2–48. (In Russ).

[6] Покровский А.В., Головюк А.Л. Состояние сосудистой хирургии в Российской Федерации в 2018 году // Ангиология и сосудистая хирургия. 2019. T. 25, № 2, прил. C. 2–48.

[7] Gaibov AD, Kalmykov EL, Kamolov AN. Thrombosis of femoral vein stump after lower limb amputation. Cardiology and Cardiovascular Surgery. 2011;4(5):71–5. (In Russ).

[8] Гаибов А.Д., Калмыков Е.Л., Камолов А.Н. Тромбоз культи бедренной вены после ампутации нижних конечностей // Кардиология и сердечно-сосудистая хирургия. 2011. T. 4, № 5. C. 71–75.

[9] Aboyans V, Ricco J–B, Bartelink M–LEL, et al. Editor’s Choice — 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(3):305–68. doi: 10.1016/j.ejvs.2017.07.018

[10] Aboyans V., Ricco J.–B., Bartelink M.–L.E.L., et al. Editor’s Choice — 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) // European Journal of Vascular and Endovascular Surgery. 2018. Vol. 55, No. 3. C. 305–368. doi: 10.1016/j.ejvs.2017.07.018

[11] Alekyan BG, Zakaryan NV, Pankov AS. The modern state of endovascular treatment of atherosclerotic and diabetic lesions of lower limb arteries in the Russian Federation. Endovascular Surgery. 2016;3(4):5–12. (In Russ).

[12] Алекян Б.Г., Закарян Н.В., Панков А.С. Современное состояние эндоваскулярного лечения атеросклеротических и диабетических поражений артерий нижних конечностей в Российской Федерации // Эндоваскулярная хирургия. 2016. T. 3, № 4. C. 5–12.

[13] Kalmykov EL, Suchkov IA, Niematzoda ON. On the problem of lumbar sympathectomy. Angiology and Vascular Surgery. 2017;23(4):181–5. (In Russ).

[14] Калмыков Е.Л., Сучков И.А., Неъматзода О. К вопросу о поясничной симпатэктомии // Ангиология и сосудистая хирургия. 2017. T. 23, № 4. C. 181–185.

[15] Gaibov AD, Kalmykov EL, Kamolov AN. Low extremity amputation in treatment of chronic critical limb ischemia (data review). Cardiology and Cardiovascular Surgery. 2009;2(2):40–6. (In Russ).

[16] Гаибов А.Д., Калмыков Е.Л., Камолов А.Н. Ампутации нижних конечностей при их хронической критической ишемии (обзор литературы) // Кардиология и сердечно-сосудистая хирургия. 2009. T. 2, № 2. C. 40–46.

[17] Mukhamadieva KhS, Gaibov AD, Baratov AK, et al. Place and value of endovascular and hybrid technologies in treatment of lower extremity peripheral artery disease. Avicenna Bulletin. 2018;20(1):103–12. (In Russ). doi: 10.25005/2074-0581-2018-20-1-103-112

[18] Мухаммадиева Х.С., Гаибов А.Д., Баратов А.К., и др. Место и значение эндоваскулярных технологий и «гибридных операций» в лечении окклюзионно-стенотических поражений артерий нижних конечностей // Вестник Авиценны. 2018. T. 20, № 1. C. 103–112. doi: 10.25005/2074-0581-2018-20-1-103-112

[19] Kalmykov EL, Mzhavanadze ND, Suchkov IA. Review of the proceedings of the 68th International congress of the European society of cardiovascular and endovascular surgery (May 22–25, 2019). Angiology and Vascular Surgery. 2020;26(1):49–53. (In Russ).

[20] Калмыков Е.Л., Мжаванадзе Н.Д., Сучков И.А. Обзор материалов 68-го международного конгресса Европейского общества кардиоваскулярных и эндоваскулярных хирургов (22–25 мая 2019 г.) // Ангиология и сосудистая хирургия. 2020. T. 26, № 1. C. 49–53.

[21] Cull DL, Langan EM, Gray BH, et al. Open versus endovascular intervention for critical limb ischemia: a population-based study. J Am Coll Surg. 2010;210(5):555–63. doi: 10.1016/j.jamcollsurg.2009.12.019

[22] Cull D.L., Langan E.M., Gray B.H., et al. Open versus endovascular intervention for critical limb ischemia: a population-based study // Journal of the American College of Surgeons. 2010. Vol. 210, No. 5. P. 555–563. doi: 10.1016/j.jamcollsurg.2009.12.019

[23] Kudo T, Chandra FA, Kwun W–H, et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg. 2006;44(2):304–13. doi: 10.1016/j.jvs.2006.03.040

[24] Kudo T., Chandra F.A., Kwun W.–H., et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery // Journal of Vascular Surgery. 2006. Vol. 44, No. 2. P. 304–313. doi: 10.1016/j.jvs.2006.03.040

[25] Iida O, Takahara M, Kohsaka S, et al. Impact of Institutional Volume on Critical In-Hospital Complications Adjusted for Patient- and Limb-Related Characteristics: An Analysis of a Nationwide Japanese Registry of Endovascular Interventions for PAD. J Endovasc Ther. 2020;27(5):739–48. doi: 10.1177/1526602820923118

[26] Iida O., Takahara M., Kohsaka S., et al. Impact of Institutional Volume on Critical In-Hospital Complications Adjusted for Patient- and Limb-Related Characteristics: An Analysis of a Nationwide Japanese Registry of Endovascular Interventions for PAD // Journal of Endovascular Therapy. 2020. Vol. 27, No. 5. P. 739–748. doi: 10.1177/1526602820923118

[27] Martini R. Trends of the treatment of Critical Limb Ischemia during the last two decades. Clin Hemorheol Microcirc. 2018;69(4):447–56. doi: 10.3233/CH-170352

[28] Martini R. Trends of the treatment of Critical Limb Ischemia during the last two decades // Clinical Hemorheology and Microcirculation. 2018. Vol. 69, No. 4. P. 447–456. doi: 10.3233/CH-170352

[29] Schramm KM, DeWitt PE, Dybul S, et al. Recent Trends in Clinical Setting and Provider Specialty for Endovascular Peripheral Artery Disease Interventions for the Medicare Population. J Vasc Interv Radiol. 2020;31(4):614–21.e2. doi: 10.1016/j.jvir.2019.10.025

[30] Schramm K.M., DeWitt P.E., Dybul S., et al. Recent Trends in Clinical Setting and Provider Specialty for Endovascular Peripheral Artery Disease Interventions for the Medicare Population // Journal of Vascular and Interventional Radiology. 2020. Vol. 31, № 4. P. 614–21.e2. doi: 10.1016/j.jvir.2019.10.025

[31] Timaran CH, Prault TL, Stevens SL, et al. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg. 2003;38(2):272–8. doi: 10.1016/s0741-5214(03)00411-7

[32] Timaran C.H., Prault T.L., Stevens S.L., et al. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions // Journal of Vascular Surgery. 2003. Vol. 38, No. 2. P. 272–278. doi: 10.1016/s0741-5214(03)00411-7

[33] Brountzos EN, Kelekis DA. Iliac artery angioplasty: technique and results. Acta Chir Belg. 2004;104(5):532–9. doi: 10.1080/ 00015458.2004.11679610

[34] Brountzos E.N., Kelekis D.A. Iliac artery angioplasty: technique and results // Acta Chirurgica Belgica. 2004. Vol. 104, No. 5. P. 532–539. doi: 10.1080/00015458.2004.11679610

[35] Kolte D, Kennedy KF, Shishehbor MH, et al. Thirty-Day Readmissions After Endovascular or Surgical Therapy for Critical Limb Ischemia: Analysis of the 2013 to 2014 Nationwide Readmissions Databases. Circulation. 2017;136(2):167–76. doi: 10.1161/CIRCULATIONAHA.117.027625

[36] Kolte D., Kennedy K.F., Shishehbor M.H., et al. Thirty-Day Readmissions After Endovascular or Surgical Therapy for Critical Limb Ischemia: Analysis of the 2013 to 2014 Nationwide Readmissions Databases // Circulation. 2017. Vol. 136, No. 2. P. 167–176. doi: 10.1161/CIRCULATIONAHA.117.027625

[37] Tran K, Ullery BW, Kret MR, et al. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease. Ann Vasc Surg. 2017;38:90–8. doi: 10.1016/j.avsg.2016.08.006

[38] Tran K., Ullery B.W., Kret M.R., et al. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease // Annals of Vascular Surgery. 2017. Vol. 38. P. 90–98. doi: 10.1016/j.avsg.2016.08.006

[39] Goode SD, Keltie K, Burn J, et al. Effect of procedure volume on outcomes after iliac artery angioplasty and stenting. Br J Surg. 2013;100(9):1189–96. doi: 10.1002/bjs.9199

[40] Goode S.D., Keltie K., Burn J., et al. Effect of procedure volume on outcomes after iliac artery angioplasty and stenting // British Journal of Surgery. 2013. Vol. 100, No. 9. P. 1189–1196. doi: 10.1002/bjs.9199

[41] Miller C, Frood R, See TC, et al. British Society of Interventional Radiology Iliac Angioplasty and Stent Registry: fourth report on an additional 8,294 procedures. Clin Radiol. 2019;74(6):429–34. doi: 10.1016/j.crad.2019.01.026

[42] Miller C., Frood R., See T.C., et al. British Society of Interventional Radiology Iliac Angioplasty and Stent Registry: fourth report on an additional 8,294 procedures // Clinical Radiology. 2019. Vol. 74, No. 6. P. 429–434. doi: 10.1016/j.crad.2019.01.026

[43] Bekken J, Jongsma H, Ayez N, et al. Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev. 2015;(5):CD007561. doi: 10.1002/14651858.CD007561.pub2

[44] Bekken J., Jongsma H., Ayez N., et al. Angioplasty versus stenting for iliac artery lesions // The Cochrane Database of Systematic Reviews. 2015. No. 5. P. CD007561. doi: 10.1002/14651858.CD007561.pub2

[45] Jongsma H, Bekken J, Ayez N, et al. Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev. 2020;12(12):CD007561. doi: 10.1002/14651858.CD007561.pub3

[46] Jongsma H., Bekken J., Ayez N., et al. Angioplasty versus stenting for iliac artery lesions // The Cochrane Database of Systematic Reviews. 2020. Vol. 12, No. 12. P. CD007561. doi: 10.1002/14651858.CD007561.pub3

[47] Piffaretti G, Fargion AT, Dorigo W, et al. Endovascular Reconstruction for Total Aorto-Iliac Occlusion. J Endovasc Ther. 2022;29(4):565–75. doi: 10.1177/15266028211059908

[48] Piffaretti G., Fargion A.T., Dorigo W., et al. Endovascular Reconstruction for Total Aorto-Iliac Occlusion // Journal of Endovascular Therapy. 2022. Vol. 29, No. 4. P. 565–575. doi: 10.1177/15266028211059908

[49] Borghese O, Ferrer C, Coscarella C, et al. Two-year single centre results with covered endovascular reconstruction of aortic bifurcation (CERAB) in the treatment of extensive aorto-iliac occlusive disease. Vascular. 2022;30(3):500–8. doi: 10.1177/17085381211018336

[50] Borghese O., Ferrer C., Coscarella C., et al. Two-year single centre results with covered endovascular reconstruction of aortic bifurcation (CERAB) in the treatment of extensive aorto-iliac occlusive disease // Vascular. 2022. Vol. 30, No. 3. P. 500–508. doi: 10.1177/17085381211018336

[51] Piffaretti G, Fargion AT, Dorigo W, et al. Outcomes From the Multicenter Italian Registry on Primary Endovascular Treatment of Aortoiliac Occlusive Disease. J Endovasc Ther. 2019;26(5):623–32. doi: 10.1177/1526602819863081

[52] Piffaretti G., Fargion A.T., Dorigo W., et al. Outcomes from the Multicenter Italian Registry on Primary Endovascular Treatment of Aortoiliac Occlusive Disease // Journal of Endovascular Therapy. 2019. Vol. 26, No. 5. P. 623–632. doi: 10.1177/1526602819863081

[53] Squizzato F, Piazza M, Pulli R, et al. Covered versus bare metal kissing stents for reconstruction of the aortic bifurcation in the ILIACS registry. J Vasc Surg. 2021;73(6):1980–90.e4. doi: 10.1016/j.jvs.2020.10.066

[54] Squizzato F., Piazza M., Pulli R., et al. Covered versus bare metal kissing stents for reconstruction of the aortic bifurcation in the ILIACS registry // Journal of Vascular Surgery. 2021. Vol. 73, No. 6. P. 1980–1990.e4. doi: 10.1016/j.jvs.2020.10.066

[55] Starodubtsev V, Mitrofanov V, Ignatenko P, et al. Editor's Choice — Hybrid vs. Open Surgical Reconstruction for Iliofemoral Occlusive Disease: A Prospective Randomised Trial. Eur J Vasc Endovasc Surg. 2022;63(4):557–65. doi: 10.1016/j.ejvs.2022.02.002

[56] Starodubtsev V., Mitrofanov V., Ignatenko P., et al. Editor's Choice — Hybrid vs. Open Surgical Reconstruction for Iliofemoral Occlusive Disease: A Prospective Randomised Trial // European Journal of Vascular and Endovascular Surgery. 2022. Vol. 63, No. 4. P. 557–565. doi: 10.1016/j.ejvs.2022.02.002

[57] Janczak D, Malinowski M, Bąkowski W, et al. Comparison of the Incidence of Complications and Secondary Surgical Interventions Necessary in Patients with Chronic Lower Limb Ischemia Treated by Both Open and Endovascular Surgeries. Ann Thorac Cardiovasc Surg. 2017;23(3):135–40. doi: 10.5761/atcs.oa.16-00282

[58] Janczak D., Malinowski M., Bąkowski W., et al. Comparison of the Incidence of Complications and Secondary Surgical Interventions Necessary in Patients with Chronic Lower Limb Ischemia Treated by Both Open and Endovascular Surgeries // Annals of Thoracic and Cardiovascular Surgery. 2017. Vol. 23, No. 3. P. 135–140. doi: 10.5761/atcs.oa.16-00282

[59] Ko Y–G, Shin S, Kim KJ, et al. Efficacy of stent-supported subintimal angioplasty in the treatment of long iliac artery occlusions. J Vasc Surg. 2011;54(1):116–22. doi: 10.1016/j.jvs.2010.11.127

[60] Ko Y.–G., Shin S., Kim K.J., et al. Efficacy of stent-supported subintimal angioplasty in the treatment of long iliac artery occlusions // Journal of Vascular Surgery. 2011. Vol. 54, No. 1. P. 116–122. doi: 10.1016/j.jvs.2010.11.127

[61] Minko P, Katoh M, Opitz A, et al. Subintimal revascularization of chronic iliac artery occlusions using a reentry-catheter. Rofo. 2011; 183(6):549–53. doi: 10.1055/s-0031-1273345

[62] Minko P., Katoh M., Opitz A., et al. Subintimal revascularization of chronic iliac artery occlusions using a reentry-catheter // Rofo. 2011. Vol. 183, No. 6. P. 549–553. doi: 10.1055/s-0031-1273345

[63] Timaran CH, Stevens SL, Freeman MB, et al. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg. 2001;34(3):440–6. doi: 10.1067/mva.2001.117148

[64] Timaran C.H., Stevens S.L., Freeman M.B., et al. External iliac and common iliac artery angioplasty and stenting in men and women // Journal of Vascular Surgery. 2001. Vol. 34, No. 3. P. 440–446. doi: 10.1067/mva.2001.117148

[65] Ebaugh JL, Gupta N, Raffetto JD. Single-incision external iliac artery endarterectomy and patch angioplasty. Ann Vasc Surg. 2011;25(8):1165–9. doi: 10.1016/j.avsg.2011.05.032

[66] Ebaugh J.L., Gupta N., Raffetto J.D. Single-incision external iliac artery endarterectomy and patch angioplasty // Annals of Vascular Surgery. 2011. Vol. 25, No. 8. P. 1165–1169. doi: 10.1016/j.avsg.2011.05.032

[67] Gaibov AD, Muhammadieva KhS, Kalmikov EL, et al. Radial diagnostics capabilities of occlusive-stenotic lesions of the lower limb arteries. Bulletin of the Academy of Medical Sciences of Tajikistan. 2016;3:3–11. (In Russ).

[68] Гаибов А.Д., Мухаммадиева Х.С., Калмыков Е.Л., и др. Возможности лучевой диагностики окклюзионно-стенотических поражений артерий нижних конечностей // Вестник Академии медицинских наук Таджикистана. 2016. № 3. C. 3–11.

[69] Zhuang J–M, Li X, Li T–R, et al. Comparison of the clinical efficacy of endovascular reconstruction versus bypass surgery for transatlantic inter-society consensus II C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans. Beijing Da Xue Xue Bao. Yi Xue Ban. 2015;47(6):957–61.

[70] Zhuang J.–M., Li X., Li T.–R., et al. Comparison of the clinical efficacy of endovascular reconstruction versus bypass surgery for transatlantic inter-society consensus II C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans // Beijing Da Xue Xue Bao. Yi Xue Ban. 2015. Vol. 47, No. 6. P. 957–961.

[71] Wang B, Wang G, Yang R. A comparison for the patency rate of TASC II C/D femoropopliteal arterial disease between endovascular treatment and arterial bypass therapy. Zhonghua Yi Xue Za Zhi. 2015;95(14):1100–3.

[72] Wang B., Wang G., Yang R. A comparison for the patency rate of TASC II C/D femoropopliteal arterial disease between endovascular treatment and arterial bypass therapy // Zhonghua Yi Xue Za Zhi. 2015. Vol. 95, No. 14. P. 1100–1103.

[73] Veraldi GF, Mezzetto L, Macrì M, et al. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study. Ann Vasc Surg. 2018;47:179–87. doi: 10.1016/j.avsg.2017.09.008

[74] Veraldi G.F., Mezzetto L., Macrì M., et al. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study // Annals of Vascular Surgery. 2018. Vol. 47. P. 179–187. doi: 10.1016/j.avsg.2017.09.008

[75] Diamantopoulos A, Katsanos K. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Surg (Torino). 2014;55(5):655–65.

[76] Diamantopoulos A., Katsanos K. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials // The Journal of Cardiovascular Surgery. 2014. Vol. 55, No. 5. P. 655–665.

[77] McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2009;49(1):109–16.E9. doi: 10.1016/j.jvs.2008.08.041

[78] McQuade K., Gable D., Hohman S., et al. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral- popliteal bypass in the treatment of superficial femoral artery occlusive disease // Journal of Vascular Surgery. 2009. Vol. 49, No. 1. P. 109–116.E9. doi: 10.1016/j.jvs.2008.08.041

[79] Zhuang J–M, Li X, Li T–R, et al. Percutaneous transluminal angioplasty versus stent implantation for treatment of femoral and popliteal artery lesion resulted from arteriosclerosis obliterans. Beijing Da Xue Xue Bao. Yi Xue Ban. 2016;48(1):160–5.

[80] Zhuang J.–M., Li X., Li T.–R., et al. Percutaneous transluminal angioplasty versus stent implantation for treatment of femoral and popliteal artery lesion resulted from arteriosclerosis obliterans // Beijing Da Xue Xue Bao. Yi Xue Ban. 2016. Vol. 48, No. 1. P. 160–165.

[81] Ben Hammamia M, Ben Mrad M, Derbel B, et al. Femoropopliteal angioplasty: Short- and mid-term results. J Med Vasc. 2017;42(4):204–2. doi: 10.1016/j.jdmv.2017.04.001

[82] Ben Hammamia M., Ben Mrad M., Derbel B., et al. Femoropopliteal angioplasty: Short- and mid-term results // Journal de Medicine Vasculaire. 2017. Vol. 42, No. 4. P. 204–212. doi: 10.1016/j.jdmv.2017.04.001

[83] Mehrotra S, Paramasivam G, Mishra S. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. Curr Cardiol Rep. 2017;19:10. doi: 10.1007/s11886-017-0823-4

[84] Mehrotra S., Paramasivam G., Mishra S. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease // Current Cardiology Reports. 2017. Vol. 19. P. 10. doi: 10.1007/s11886-017-0823-4

[85] Kinstner CM, Lammer J, Willfort–Ehringer A, et al. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. JACC Cardiovasc Interv. 2016;9(13):1386–92. doi: 10.1016/j.jcin.2016.04.012

[86] Kinstner C.M., Lammer J., Willfort–Ehringer A., et al. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial // JACC. Cardiovascular Interventions. 2016. Vol. 9, No, 13. P. 1386–1392. doi: 10.1016/j.jcin.2016.04.012

[87] Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv. 2013;6(12):1295–302. doi: 10.1016/j.jcin.2013.07.010

[88] Liistro F., Grotti S., Porto I., et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery) // JACC. Cardiovascular Interventions. 2013. Vol. 6, No. 12. P. 1295–1302. doi: 10.1016/j.jcin.2013.07.010

[89] Gray WA, Cardenas JA, Brodmann M, et al. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study. JACC Cardiovasc Interv. 2019;12(23):2375–84. doi: 10.1016/j.jcin.2019.08.005

[90] Gray W.A., Cardenas J.A., Brodmann M., et al. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study // JACC. Cardiovascular Interventions. 2019. Vol. 12, No. 23. P. 2375–2384. doi: 10.1016/j.jcin.2019.08.005

[91] Sayed A, Taha A, Elkholy M, et al. Tibial angioplasty in diabetic patients: should all vessels be treated? Int Angiol. 2012;31(3):239–44.

[92] Sayed A., Taha A., Elkholy M., et al. Tibial angioplasty in diabetic patients: should all vessels be treated? // International Angiology. 2012. Vol. 31, No. 3. P. 239–244.

[93] Baumann F, Fust J, Engelberger RP, et al. Early recoil after balloon angioplasty of tibial artery obstructions in patients with critical limb ischemia. J Endovasc Ther. 2014;21(1):44–51. doi: 10.1583/13-4486MR.1

[94] Baumann F., Fust J., Engelberger R.P., et al. Early recoil after balloon angioplasty of tibial artery obstructions in patients with critical limb ischemia // Journal of Endovascular Therapy. 2014. Vol. 21, No. 1. P. 44–51. doi: 10.1583/13-4486MR.1

[95] Hsu CC–T, Kwan GN, Singh D, et al. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia. Cochrane Database Syst Rev. 2018;12(12):CD009195. doi: 10.1002/14651858.CD009195.pub2

[96] Hsu C.C.–T., Kwan G.N., Singh D., et al. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia // The Cochrane Database of Systematic Reviews. 2018. Vol. 12, No. 12. P. CD009195. doi: 10.1002/14651858.CD009195.pub2

[97] Werneck CCF, Lindsay TF. Tibial angioplasty for limb salvage in high-risk patients and cost analysis. Ann Vasc Surg. 2009;23(5):554–9. doi: 10.1016/j.avsg.2009.05.007

[98] Werneck C.C.F., Lindsay T.F. Tibial angioplasty for limb salvage in high-risk patients and cost analysis // Annals of Vascular Surgery. 2009. Vol. 23, No. 5. P. 554–559. doi: 10.1016/j.avsg.2009.05.007

RIGHTS & PERMISSIONS

Eco-Vector